Raphael Rottgen News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Raphael Rottgen. Real-time updates on events, politics, business and more.

Lexaria Bioscience Corp.: Lexaria Discusses Valuation Metrics for Biotech Industry

August 11, 2022

Third Party Analysis for Biotech and Pharma IndustriesKELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator

Raphael Rottgen George Jurcic Lexaria Bioscience Corp Drug Administration Pharma Industries Third Party Analysis For Biotech

Source: finanznachrichten.de

The Power of Science to Stop a Killer

August 9, 2022

/PRNewswire/ -- Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million...

New York United States City Of United Kingdom Atnahs Pharma Chris Bunka

Source: prnewswire.com

The Power of Science to Stop a Killer

August 8, 2022

/PRNewswire/ -- Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million...

New York United States City Of United Kingdom Atnahs Pharma Chris Bunka

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Raphael Rottgen News Today

Lexaria Bioscience Corp.: Lexaria Discusses Valuation Metrics for Biotech Industry

The Power of Science to Stop a Killer

The Power of Science to Stop a Killer

Explore More Categories